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Background
PAR1 (Protease-Activated Receptor 1) is an oncogene that
has long been proposed to be involved in the invasive and
metastatic process of breast cancer. PAR1 activates
Mitogen-Activated Protein Kinases (p44 and p42 also
called ERK1/2) leading to cell proliferation. It has been
suggested hyperexpression of the MAP Kinases may be a
key process in the metastatic potential of breast cancer.
PAR1 signaling mechanisms are not completely under-
stood. The aim of this study was to determinate ERKs acti-
vation in relation to PAR1 expression leading to tumor
progression on breast cancer cell lines.
Materials and methods
We assayed by immunoblot PAR-1 and ERKs expression
and activation on a highly invasive MDA-MB-231 and
minimally invasive MCF-7 breast cancer cell lines. We also
determined PAR1-induced cell proliferation and invasion.
To determine ERKs specific contribution to tested activi-
ties, we used U0126 MEK inhibitor. Additionally we eval-
uate their ability to growth on 3D cultures. Two tailed
Student's test was used to compare data. P values ≤ 0.05
were considered significant.
Results
We found invasive cells overexpressed PAR1, and when
stimulated with thrombin (1 nM), we observed a selective
and time independent ERK1 activation (P < 0.05). Cell
proliferation and invasion were also significantly
increased (83% ± 0.05% stimulation above media con-
trol, P < 0.02; and 87% ± 0.05% cell invasion compared
with media control, P < 0.05 respectively). All activities
were blocked significantly when assayed in the presence
of U0126 (P < 0.0001). Spheroid's size was elevated upon
thrombin stimulation and elongated in shape. In contrast
in the low invasive cell line we found very low levels of
PAR1. We observed thrombin-induced an up-modulation
of ERKs activation. ERK1 showed a maximal activation at
30 minutes, while ERK2 was barely activated in a time
independent way. No significant increase was found on
cell proliferation or invasion. Neither between spheroid's
sizes, and they were all round.
Conclusion
Our data suggest different modulation of signaling path-
ways induced by PAR1 leading to tumor progression in
breast cancer.
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